Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMC Infectious Diseases|July 12, 2019
Are current guidelines adapted for patient eligibility to PrEP? A case reportElise K Van Obberghen, Delphine Viard, Alain Lafeuillade, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 12, 2023
The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with TriptansDiane Merino, Alexandre O Gérard, Elise K Van Obberghen, et al.The Journal of Headache and Pain|May 3, 2022
Calcitonin gene-related peptide-targeting drugs and Raynaud's phenomenon: a real-world potential safety signal from the WHO pharmacovigilance databaseAlexandre O Gérard, Diane Merino, Elise K Van Obberghen, et al.Journal of Geriatric Cardiology : JGC|December 20, 2019
Major bleeding events in octagenarians associated with drug interactions between dabigatran and P-gp inhibitorsMarjorie Bernier, Sarah-Line Lancrerot, Fanny Rocher, et al.Headache|July 6, 2026
Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databasesElise K Van Obberghen, Laura Parigny, Nouha Ben-Othman, et al.Fundamental & Clinical Pharmacology|January 6, 2022
Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipientsSerena Romani, Audrey Fresse, Nadège Parassol-Girard, et al.Frontiers in Pharmacology|June 7, 2022
COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety DatabaseDiane Merino, Alexandre O Gérard, Elise K Van Obberghen, et al.Journal of Clinical Medicine|July 9, 2022
Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality AnalysisDiane Merino, Alexandre O Gérard, Elise K Van Obberghen, et al.Pageof 1